Overview
Adrian Navarro-Marquez practices practicing medicine in Mexico City, Mexico.
His clinical expertise encompasses Folliculitis, Blepharitis, and Cysticercosis.
He is actively involved in clinical research, co-authoring 13 peer reviewed articles.
Gender
Locations
La Ciudad, DUR, Mexico
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Adrian Navarro-Marquez
Is Adrian Navarro-Marquez a top-rated expert for Folliculitis?
MediFind is an objective health platform that identifies experts based on real-world data. Adrian Navarro-Marquez is classified as an Experienced expert for Folliculitis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Adrian Navarro-Marquez participate in research or clinical trials?
Yes. Adrian Navarro-Marquez has published 13 articles and abstracts on conditions like Folliculitis. You can view a list of Adrian Navarro-Marquez's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- BlepharitisMr. Navarro-Marquez isExperienced. Learn about Blepharitis.
- CysticercosisMr. Navarro-Marquez isExperienced. Learn about Cysticercosis.
- FolliculitisMr. Navarro-Marquez isExperienced. Learn about Folliculitis.